摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-Dihydro-4-(3-iodophenylureido)-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-1-one | 1040236-84-7

中文名称
——
中文别名
——
英文名称
1,2-Dihydro-4-(3-iodophenylureido)-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-1-one
英文别名
1-(3-iodophenyl)-3-(1-oxo-2-phenyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-yl)urea
1,2-Dihydro-4-(3-iodophenylureido)-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-1-one化学式
CAS
1040236-84-7
化学式
C22H15IN6O2
mdl
——
分子量
522.305
InChiKey
DVZVMTRMOQLIJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    31
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    89.4
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-碘苯异氰酸酯4-Amino-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one四氢呋喃 为溶剂, 反应 3.0h, 以95%的产率得到1,2-Dihydro-4-(3-iodophenylureido)-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-1-one
    参考文献:
    名称:
    Synthesis, ligand–receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists
    摘要:
    The study of some 4-substituted-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives, designed as hA(3) adenosine receptor antagonists, is reported. The new compounds bear on the four-position different acylamino, sulfonylamino, benzylureido and benzyloxy moieties, which have also been combined with a para-methoxy group on the 2-phenyl ring or with a nitro residue at the six-position. Many derivatives show high hA(3) adenosine receptor affinities and selectivities both versus hA(1) and hA(2A) receptors. The observed structure-affinity relationships of this class of antagonists have been exhaustively rationalized using the recently published ligand-based homology modeling (LBHM) approach. The selected 4-bismethanesulfonylamino-2-phenyl-1,2,4-triazolo[4,3a]quinoxalin-1-one (13), which shows high hA(3) affinity (K-i = 5.5 nM) and selectivity versus hA(1), hA(2A) (both selectivity ratios > 1800) and hA(2B) (cAMP assay, IC50 > 10,000 nM) receptors, was tested in an in vitro rat model of cerebral ischemia, proving to be effective in preventing the failure of synaptic activity, induced by oxygen and glucose deprivation in the hippocampus, and in delaying the occurrence of anoxic depolarization. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.04.039
点击查看最新优质反应信息